Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Motives for choosing, switching and stopping daily or event-driven pre-exposure prophylaxis - a qualitative analysis.

Zimmermann HM, Eekman SW, Achterbergh RC, Schim van der Loeff MF, Prins M, de Vries HJ, Hoornenborg E, Davidovich U; Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Consortium (H-TEAM).

J Int AIDS Soc. 2019 Oct;22(10):e25389. doi: 10.1002/jia2.25389.

2.

Identification and characterization of latent classes based on drug use among men who have sex with men at risk of sexually transmitted infections in Amsterdam, the Netherlands.

Achterbergh RCA, de Vries HJC, Boyd A, Davidovich U, Drückler S, Hoornenborg E, Prins M, Matser A.

Addiction. 2019 Aug 10. doi: 10.1111/add.14774. [Epub ahead of print]

PMID:
31400174
3.

Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.

Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, Schim van der Loeff MF, Boyd A, van Duijnhoven YTHP, Bruisten S, Oostvogel P, Davidovich U, Hogewoning A, Prins M, de Vries HJC; Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam (H-TEAM) Initiative.

Lancet HIV. 2019 Jul;6(7):e447-e455. doi: 10.1016/S2352-3018(19)30136-5. Epub 2019 Jun 6.

PMID:
31178284
4.

A Mobile Application to Collect Daily Data on Preexposure Prophylaxis Adherence and Sexual Behavior Among Men Who Have Sex With Men: Use Over Time and Comparability With Conventional Data Collection.

Finkenflügel RNN, Hoornenborg E, Achterbergh RCA, Marra E, Davidovich U, de Vries HJC, Prins M, Schim van der Loeff MF; Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative (H-TEAM).

Sex Transm Dis. 2019 Jun;46(6):400-406. doi: 10.1097/OLQ.0000000000000999.

5.

Physicians' preparedness for pre-exposure prophylaxis: results of an online survey in Belgium.

Reyniers T, Vuylsteke B, Pirotte B, Hoornenborg E, Bil JP, Wouters K, Laga M, Nöstlinger C.

Sex Health. 2018 Nov;15(6):606-611. doi: 10.1071/SH18072.

PMID:
30384876
6.

Error in the calculation of person-time in the before-PrEP period by Beymer et al.

Hulstein SH, Hoornenborg E, van der Loeff MFS.

Sex Transm Infect. 2018 Nov;94(7):514. doi: 10.1136/sextrans-2018-053795. No abstract available.

PMID:
30337430
7.

Pre-exposure prophylaxis among men who have sex with men in the Amsterdam Cohort Studies: Use, eligibility, and intention to use.

Coyer L, van Bilsen W, Bil J, Davidovich U, Hoornenborg E, Prins M, Matser A.

PLoS One. 2018 Oct 12;13(10):e0205663. doi: 10.1371/journal.pone.0205663. eCollection 2018.

8.

Change in sexual risk behaviour after 6 months of pre-exposure prophylaxis use: results from the Amsterdam pre-exposure prophylaxis demonstration project.

Hoornenborg E, Coyer L, van Laarhoven A, Achterbergh R, de Vries H, Prins M, van der Loeff MS; Amsterdam PrEP Project team in the HIV Transmission Elimination Amsterdam Initiative.

AIDS. 2018 Jul 17;32(11):1527-1532. doi: 10.1097/QAD.0000000000001874.

PMID:
29762169
9.

Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam.

Hoornenborg E, Achterbergh RC, van der Loeff MFS, Davidovich U, van der Helm JJ, Hogewoning A, van Duijnhoven YT, Sonder GJ, de Vries HJ, Prins M; Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative.

J Int AIDS Soc. 2018 Mar;21(3):e25105. doi: 10.1002/jia2.25105.

10.

The Acceptability of Pre-Exposure Prophylaxis: Beliefs of Health-Care Professionals Working in Sexually Transmitted Infections Clinics and HIV Treatment Centers.

Bil JP, Hoornenborg E, Prins M, Hogewoning A, Dias Goncalves Lima F, de Vries HJC, Davidovich U.

Front Public Health. 2018 Feb 9;6:5. doi: 10.3389/fpubh.2018.00005. eCollection 2018.

11.

Wild-type HIV infection despite PrEP: a lot to learn from a case report - Authors' reply.

Hoornenborg E, Prins M, Prins JM, de Bree GJ.

Lancet HIV. 2018 Jan;5(1):e10-e11. doi: 10.1016/S2352-3018(17)30214-X. No abstract available.

PMID:
29290224
12.

Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries.

Hoornenborg E, Krakower DS, Prins M, Mayer KH.

AIDS. 2017 Oct 23;31(16):2179-2191. doi: 10.1097/QAD.0000000000001627. Review.

13.

Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report.

Hoornenborg E, Prins M, Achterbergh RCA, Woittiez LR, Cornelissen M, Jurriaans S, Kootstra NA, Anderson PL, Reiss P, de Vries HJC, Prins JM, de Bree GJ; Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Consortium (H-TEAM).

Lancet HIV. 2017 Nov;4(11):e522-e528. doi: 10.1016/S2352-3018(17)30132-7. Epub 2017 Sep 14.

PMID:
28919303
14.

Sexually transmitted infections: challenges ahead.

Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, Marrazzo JM, Sonder GJB, Schwebke JR, Hoornenborg E, Peeling RW, Philip SS, Low N, Fairley CK.

Lancet Infect Dis. 2017 Aug;17(8):e235-e279. doi: 10.1016/S1473-3099(17)30310-9. Epub 2017 Jul 9. Review.

PMID:
28701272
15.

MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection.

Hoornenborg E, Achterbergh RCA, Schim van der Loeff MF, Davidovich U, Hogewoning A, de Vries HJC, Schinkel J, Prins M, van de Laar TJW; Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative, MOSAIC study group.

AIDS. 2017 Jul 17;31(11):1603-1610. doi: 10.1097/QAD.0000000000001522.

PMID:
28657964
16.

Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool.

Reyniers T, Hoornenborg E, Vuylsteke B, Wouters K, Laga M.

Sex Transm Infect. 2017 Aug;93(5):363-367. doi: 10.1136/sextrans-2016-052699. Epub 2016 Nov 21. Review.

PMID:
27872326
17.

Jaw enlargement in a haemodialysis patient. Secondary hyperparathyroidism.

Hoornenborg E, van Delft F, Vogt L.

Neth J Med. 2014 May;72(4):229, 233. No abstract available.

18.

Two cases with acute abdominal aneurysm and evidence of acute Q fever infection.

Hagenaars JC, Kampschreur LM, de Jager-Leclercq MG, van Petersen AS, Moll FL, Renders NH, Wever PC, Koning OH, Hoornenborg E.

Ann Vasc Surg. 2014 Feb;28(2):494.e1-3. doi: 10.1016/j.avsg.2013.03.022. Epub 2013 Dec 22.

PMID:
24368182
19.

Serpentine movements in a patient with Chilaiditi's sign.

van Delft F, Hoornenborg E.

Clin Gastroenterol Hepatol. 2014 Aug;12(8):e67-8. doi: 10.1016/j.cgh.2013.11.018. Epub 2013 Nov 20. No abstract available.

PMID:
24269924
20.

Delayed diagnosis of chronic Q fever and cardiac valve surgery.

Kampschreur LM, Hoornenborg E, Renders NH, Oosterheert JJ, Haverman JF, Elsman P, Wever PC.

Emerg Infect Dis. 2013 May;19(5):768-70. doi: 10.3201/eid1905.120353.

21.

[Pulmonary toxicity resulting from the use of nitrofurantoin].

Broes MJ, Roelofs BF, Mudde AH, Hoornenborg E.

Ned Tijdschr Geneeskd. 2012;156(44):A4990. Dutch.

PMID:
23114172
22.

Bringing global issues to medical teaching.

Bateman C, Baker T, Hoornenborg E, Ericsson U.

Lancet. 2001 Nov 3;358(9292):1539-42. No abstract available.

PMID:
11705584

Supplemental Content

Loading ...
Support Center